Infra stock jumps 5% after receiving ₹1,480 Cr order from Bihar Medical Services Corp.

Published 24-03-2025, 11:12 am
© Reuters.  Infra stock jumps 5% after receiving ₹1,480 Cr order from Bihar Medical Services Corp.

This infra stock, which undertakes turnkey EPC contracts and BOT projects, jumped up to 5 percent in the day’s trade upon receiving a new work order worth Rs. 1,480 crore from Bihar Medical (TASE:BLWV) Services Corp.

Stock Performance

With a market capitalization of Rs. 13,225.59 crores, the shares of NCC Ltd (NSE:NCCL) went up nearly 5 percent to an intraday high of Rs. 215.95 per share compared to the previous closing price of Rs 206.05.

The stock retraced and was trading at Rs. 210.65, marking a 2 percent increase from the previous close.

ProPicks AI is now LIVE in India. ProPicks Strategies utilizes a blend of artificial intelligence (AI) and expert human analysis to spotlight stocks with the potential to outperform market benchmarks. Our Strategies such as Bharat Market Outperformers, Bharat Infra Titans, Bharat Mid-Cap Movers, Bharat Bargains, and Bharat Small Cap Gems have all beaten their respective benchmarks by handsome margins. To view February stock picks by AI, and make use of all other InvestingPro’s features such as Stock Screener, Fair Value, Financial Health, etc., avail Pro+ plan at a 45% discount here.

What Happened

NCC Ltd received a work order of Rs. 1,480.34 crore from Bihar Medical Services & Infrastructure Corporation Limited for the Redevelopment of Darbhanga Medical College & Hospital (DMCH) along with other buildings at the campus of DMCH. The tenure for construction is set at 42 months and for DLP at 36 months.

Company Overview

NCC Limited (NSE:NCCL) (formerly known as Nagarjuna Construction Company Limited) is a large Construction and Infrastructure Development Company. They have been participating in various tenders floated on a regular basis and bagging contracts with major clients including Adani, IOC, MMRC, RVNL and NHAI.

Financials

Looking at the latest financial performance, the company reported a muted 2 percent increase in revenue from Rs 5,260 crore in Q3 FY24 to Rs 5,345 crore in Q3 FY25. This was accompanied by a 14 percent decline in net profits from Rs 231 crore to Rs 206 crore during the same period.

Order Book Analysis

The company has a diversified order book of Rs.55,548 crores. The order inflow for Q3 FY25 stood at Rs. 8,440 crores. About 38 percent of the company’s order book comes from buildings.

Other prominent businesses being Transportation, Electrical (T&D), Water and Railways, Irrigation, Mining and so on. State wise, maximum orders for the company come from areas like Maharashtra, Uttar Pradesh, Karnataka and others.

Written by Shwetha Sairam

Disclaimer

The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post Infra stock jumps 5% after receiving ₹1,480 Cr order from Bihar Medical Services Corp. appeared first on Trade Brains.

Read More

To subscribe to India’s top stocks in 2025 through ProPicks AI, click here:

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.